Floating Button
Home News Covid-19

Singapore expert committee backs Pfizer-BioNTech vaccine

Bloomberg
Bloomberg • 2 min read
Singapore expert committee backs Pfizer-BioNTech vaccine
Singapore’s first batch of Pfizer and BioNTech shots arrived last week.
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

A group of top Singapore health experts backed the government’s move to approve the Pfizer Inc. and BioNTech SE’s coronavirus vaccine after it conducted an independent review of clinical data on its safety and efficacy.

The vaccine demonstrated a high efficacy rate of 95% and its safety profile is consistent with the high standards set for other registered vaccines used in immunization against other diseases, the committee of experts said in a statement issued by the health ministry on Sunday. It is suitable for use for those aged 16 and above, and is expecting further trial data on other groups, such as pregnant women, the committee said.

The government said separately on Sunday that it’s accepting the committee’s recommendations, and will begin vaccinating health care workers from Dec. 30. The elderly, starting with those aged 70 and above, is targeted to get their shots from February.

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2026 The Edge Publishing Pte Ltd. All rights reserved.